PROLOR Biotech to Present at Jefferies 2011 Global Healthcare Conference

NES-ZIONA, Israel, May 31, 2011 /PRNewswire/ -- PROLOR Biotech, Inc., (NYSE Amex: PBTH), a clinical stage company developing next generation biobetter therapeutic proteins, today announced that company management will give a corporate presentation at the Jefferies 2011 Global Healthcare Conference on June 6, 2011 at 9:30 AM ET.

A live webcast of the company's presentation will be available in the Investors section of PROLOR's website at www.prolor-biotech.com/?CategoryID=215, or at the Jefferies conference webcast center at www.wsw.com/webcast/jeff60/pbth/.  A replay will be available on the PROLOR website and will be archived for at least 30 days.

The Jefferies 2011 Global Healthcare Conference will be held June 6-9, 2011 at the Grand Hyatt Hotel in New York City.  For more information, visit:  www.jefferies.com/cositemgr.pl/html/OurFirm/ConferencesEvents/index.shtml.

ABOUT PROLOR BIOTECH

PROLOR Biotech, Inc. is a clinical stage biopharmaceutical company applying unique technologies, including its patented CTP technology and Reversible Pegylation technology, primarily to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales.  The CTP technology is applicable to virtually all proteins and the Reversible Pegylation technology is well-suited for use with peptides and small molecule therapeutics.  PROLOR is currently developing long-acting versions of human growth hormone, which is in Phase II clinical development, and Factor IX, Factor VII, interferon beta and erythropoietin, which are in preclinical development, as well as an anti-obesity peptide and agents for atherosclerosis and rheumatoid arthritis.  For more information, visit www.prolor-biotech.com.

SOURCE PROLOR Biotech, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED